The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO 2024 | Transplantation in elderly patients with multiple myeloma without access to new drugs
Phillip Scheinberg, MD, PhD, Beneficencia Portuguesa de Sao Paulo, São Paulo, Brazil, discusses the use of transplantation in elderly patients with multiple myeloma in Brazil, where access to other therapies is limited. Dr Scheinberg says that this treatment option is viable and effective in this patient population, with relatively low treatment-related mortality. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
